The Importance of Maternal Immunization

Originally presented on July 21, 2016

Rhoda Sperling, MD
Professor of Obstetrics, Gynecology and Reproductive Science and Infectious Disease Medicine, Mount Sinai Medical Center

Elizabeth Rausch-Phung, MD, MPH
Director, Bureau of Immunization, New York State Department of Health


Increasing the availability, accessibility and use of evidence-based interventions to increase Influenza and Tetanus, Diphtheria and Pertussis (Tdap) immunization rates for pregnant women is a key goal of the New York State Prevention Agenda. Implementation of immunization programs as part of routine obstetrical care supports best practice and national standards for prenatal care. Despite scientific evidence supporting influenza and Tdap vaccination and recommendations from the Advisory Committee on Immunization Practice (ACIP), the American College of Obstetricians and Gynecologists (ACOG) and the American Academy of Pediatrics (AAP), immunization rates for pregnant women remain low. Maternal immunization protects infants from serious illness until they are old enough to be immunized and pregnant women from significant complications related to these vaccine-preventable diseases. These benefits underscore the need for OB/GYN practices to identify and reduce barriers so they may implement an effective prenatal immunization program.

This webcast will review current recommendations and best practices for maternal immunization, the benefits of immunization against influenza and Tdap, as well as recommendations for putting successful prenatal immunization programs into practice. 

Learning Objectives
After watching this webcast participants will be able to:

  • Identify maternal vaccination recommendations;
  • Name at least three benefits of maternal immunization; and
  • Recognize evidence-based maternal immunization best practices.

Continuing Education Credits expired for this activity on July 31, 2019. Please take the evaluation as your feedback helps us to plan future programs.

Thank you!